Clinical Trials

78 enrolled

Metastatic Castration-resistant Prostate Cancer (mCRPC)

NCT05311618 2024-04-01

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

71 enrolled

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Melanoma, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT04088968 2024-03-22

STRONG-CS

100 enrolled

GenitourinaryOther

Alcohol Drinking, Motor Activity, Obesity, Postoperative Complications, Smoking, Urologic Neoplasms, Risk Reduction Behavior, Malnutrition, Patient Preference

NCT01851018 2024-03-21

HyBraFi

Prostatic Neoplasms

NCT06322745 2024-03-21

Thulium Beam Coagulation Versus Suture Renorrhaphy for Hemostasis of Tumor Bed in Laparoscopic Partial Nephrectomy

Carcinoma, Renal Cell

NCT06324058 2024-03-21

Cryoablation Versus BCG Instillation Therapy for High-risk NMIBC

190 enrolled

Urinary Bladder Neoplasms

NCT03795337 2024-03-20

HYPOSTAT-II

475 enrolled

Prostatic Neoplasms

NCT06317298 2024-03-19

Fruquintinib Plus Everolimus as 2nd Line Therapy of ccRCC Patients Progressed Post IO and TKI Therapy

36 enrolled

Carcinoma, Renal Cell

NCT01802242 2024-03-18

Tumor TARGET Prostate Cancer

85 enrolled

Prostatic Neoplasms

NCT04997252 2024-03-18

An Evaluation of the Efficacy and Safety of Apalutamide as Neoadjuvant Endocrine Therapy in High-Risk and Oligometastatic Prostate Cancer

GastrointestinalGenitourinary

High-Risk and Oligometastatic Prostate Cancer

NCT05726136 2024-03-18

FC-VE

Phase 4 Unknown

60 enrolled

Neoplasms, Urologic Neoplasms, Colorectal Neoplasms

NCT04903873 2024-03-15

A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

Phase 1/2 Unknown

110 enrolled

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Prostatic Neoplasms

NCT05740488 2024-03-15

Efficacy and Safety of Apalutamide in Combination With 89Sr as Neoadjuvant Therapy in Prostate Cancer With ≤10 Bone Metastases

Prostate Cancer With ≤10 Bone Metastases

NCT06313775 2024-03-15

Comparison of Spinal Anesthesia and Spermatic Cord Block for Bilateral Orchiectomy

18 enrolled

Prostatic Neoplasms

NCT05671900 2024-03-08

Gemcitabine and Docetaxel Therapy in High-risk BCG-naive Patients With Non-muscle Invasive Bladder Cancer

70 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT03580109 2024-03-06

THERMOEDEME

BreastGenitourinaryLymphoid

160 enrolled

Breast Neoplasms, Lymphedema, Lymphoma, Prostatic Neoplasms

NCT04544748 2024-03-06

A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies

DermatologicGenitourinaryThoracic

48 enrolled

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Neoplasms by Histologic Type, Urologic Neoplasms

NCT05946161 2024-02-29

Testing an e-Health Intervention for Prostate Cancer Survivors' Mental and Sexual Health

Psychological Well-Being, Prostatic Neoplasms

NCT04641078 2024-02-28

DART

124 enrolled

Neoplasm Metastasis, Prostatic Neoplasms

NCT05627752 2024-02-28

Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage

Phase 2/3 Unknown

120 enrolled

Prostatic Neoplasms

NCT06032910 2024-02-28

Surgical Mesh in Radical Cystectomy to Prevent Parastomal Hernias

25 enrolled

Urinary Bladder Neoplasms, Hernia

NCT06274684 2024-02-28

Feasibility of Virtual Reality Assistance in Prostate Biopsy Under Local Anesthesia.

100 enrolled

Anxiety Disorders, Prostatic Neoplasms

NCT04492293 2024-02-26

An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer

115 enrolled

Bladder Urothelial Cancer

NCT06258486 2024-02-26

Ultrasound Guided Inguinal Indocyanine Green Injection to Identify and Pre-emptively Seal Lymphatic Leaks

Phase 4 Unknown

100 enrolled

Lymphocele, Prostatic Neoplasms

NCT02077335 2024-02-21

Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate Cancer

Prostatic Neoplasms

NCT06251492 2024-02-20

Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID)

Prostate Cancer Metastatic

NCT06253091 2024-02-20

Comparison of the Application of Robot-assisted Laparoscopic Pathways in Radical Cystectomy

Urinary Bladder Neoplasms

NCT03924466 2024-02-16

VUBAR

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

55 enrolled

Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT06148220 2024-02-16

A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors

20 enrolled

GenitourinaryLymphoid

Kidney Neoplasms, Lymphoma

NCT05612204 2024-02-14

BIOPROSTATIRM

Prostatic Neoplasms

NCT05626101 2024-02-13

Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study

280 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05829057 2024-02-13

The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1

GastrointestinalGenitourinaryGynecologicThoracic

10 enrolled

Urinary Bladder Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Neoplasms, Ovarian Neoplasms, Small Cell Lung Carcinoma

NCT05587192 2024-02-12

RPWPB

57 enrolled

Disease, Prostatic Neoplasms

NCT03899077 2024-02-07

SAVE

202 enrolled

Prostatic Neoplasms

NCT04149691 2024-02-07

Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies

GastrointestinalGenitourinaryGynecologicSarcoma

42 enrolled

Urinary Bladder Neoplasms, Carcinoma, Neoplasms, Sarcoma, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT04419402 2024-02-07

ENZA-p

162 enrolled

Metastatic Castration-Resistant Prostate Cancer

NCT05947188 2024-02-05

CMNDPC

808 enrolled

Disease, Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT04599218 2024-02-02

MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer

1,586 enrolled

Prostatic Diseases, Prostatic Neoplasms

NCT04656678 2024-02-02

Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer

200 enrolled

Prostatic Diseases, Prostatic Neoplasms

NCT05787535 2024-02-02

HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor

GastrointestinalGenitourinaryGynecologicHead & Neck

17 enrolled

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT05567588 2024-02-01

Pembrolizumab Plus Radiotherapy for Advanced Renal Cancer

66 enrolled

Clear-cell metastatic renal cell carcinoma

NCT05861947 2024-01-31

JIVAN